A key feature of emerging markets is that patients often have to pay for a high proportion of their healthcare costs themselves. For all but the most severe conditions, public reimbursement of medication is often partial to non-existent, particularly in the outpatient setting. In this video Emerging Markets Director Marc Yates discusses the opportunities and challenges for pharma in self-pay markets and outlines what these mean for healthcare market research.